148 related articles for article (PubMed ID: 2883442)
1. Prediction of rapid bone loss in postmenopausal women.
Christiansen C; Riis BJ; Rødbro P
Lancet; 1987 May; 1(8542):1105-8. PubMed ID: 2883442
[TBL] [Abstract][Full Text] [Related]
2. New methods for identifying "at risk" patients for osteoporosis.
Christiansen C; Riis BJ
Clin Rheumatol; 1989 Jun; 8 Suppl 2():52-5. PubMed ID: 2788064
[TBL] [Abstract][Full Text] [Related]
3. Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 year study.
Hansen MA; Overgaard K; Riis BJ; Christiansen C
BMJ; 1991 Oct; 303(6808):961-4. PubMed ID: 1954420
[TBL] [Abstract][Full Text] [Related]
4. Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study.
Bagger YZ; Tankó LB; Alexandersen P; Hansen HB; Møllgaard A; Ravn P; Qvist P; Kanis JA; Christiansen C
Bone; 2004 Apr; 34(4):728-35. PubMed ID: 15050905
[TBL] [Abstract][Full Text] [Related]
5. Potential value of urinary oestrogen assays in the identification of fast bone losers after the menopause.
Walkinshaw MH; Mole PA; Paterson CR
Osteoporos Int; 1992 Jul; 2(4):205-9. PubMed ID: 1611227
[TBL] [Abstract][Full Text] [Related]
6. Is heritability a risk factor for postmenopausal osteoporosis?
Hansen MA; Hassager C; Jensen SB; Christiansen C
J Bone Miner Res; 1992 Sep; 7(9):1037-43. PubMed ID: 1414496
[TBL] [Abstract][Full Text] [Related]
7. [Postmenopausal osteoporosis: how to detect women-at-risk?].
Casez JP
Schweiz Rundsch Med Prax; 1991 Apr; 80(16):428-30. PubMed ID: 2038640
[TBL] [Abstract][Full Text] [Related]
8. Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment.
Civitelli R; Gonnelli S; Zacchei F; Bigazzi S; Vattimo A; Avioli LV; Gennari C
J Clin Invest; 1988 Oct; 82(4):1268-74. PubMed ID: 3262626
[TBL] [Abstract][Full Text] [Related]
9. 17 Beta-estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women.
Christiansen C; Riis BJ
J Clin Endocrinol Metab; 1990 Oct; 71(4):836-41. PubMed ID: 2205624
[TBL] [Abstract][Full Text] [Related]
10. Comparisons of noninvasive bone mineral measurements in assessing age-related loss, fracture discrimination, and diagnostic classification.
Grampp S; Genant HK; Mathur A; Lang P; Jergas M; Takada M; Glüer CC; Lu Y; Chavez M
J Bone Miner Res; 1997 May; 12(5):697-711. PubMed ID: 9144335
[TBL] [Abstract][Full Text] [Related]
11. Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis.
Lindsay R; Nieves J; Formica C; Henneman E; Woelfert L; Shen V; Dempster D; Cosman F
Lancet; 1997 Aug; 350(9077):550-5. PubMed ID: 9284777
[TBL] [Abstract][Full Text] [Related]
12. Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy.
Christiansen C; Christensen MS; Transbøl I
Lancet; 1981 Feb; 1(8218):459-61. PubMed ID: 6110089
[TBL] [Abstract][Full Text] [Related]
13. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
Langdahl BL; Loft AG; Møller N; Weeke J; Eriksen EF; Mosekilde L; Charles P
J Bone Miner Res; 1997 Jan; 12(1):78-88. PubMed ID: 9240729
[TBL] [Abstract][Full Text] [Related]
14. Does calcium potentiate the effect of estrogen therapy on postmenopausal bone loss?
Riis BJ; Nilas L; Christiansen C
Bone Miner; 1987 Feb; 2(1):1-9. PubMed ID: 3504720
[TBL] [Abstract][Full Text] [Related]
15. Cortisol secretion, bone health, and bone loss: a cross-sectional and prospective study in normal non-osteoporotic women in the early postmenopausal period.
Osella G; Ventura M; Ardito A; Allasino B; Termine A; Saba L; Vitetta R; Terzolo M; Angeli A
Eur J Endocrinol; 2012 May; 166(5):855-60. PubMed ID: 22312036
[TBL] [Abstract][Full Text] [Related]
16. Osteodensitometry in healthy postmenopausal women.
Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
[TBL] [Abstract][Full Text] [Related]
17. [Analytic study of the reliability of an integrated mineralometric and biochemical system in the dynamic evaluation of the bone mineral content after menopause].
Carone D; Miglionico F; Vizziello G; Fanizza G
Minerva Ginecol; 1994 Apr; 46(4):161-5. PubMed ID: 8065588
[TBL] [Abstract][Full Text] [Related]
18. [Is there a role for a random measurement of 24-hour urine calcium excretion and serum total alkaline phosphatase in the determination of fracture risk in osteoporotic postmenopausal women?].
Barbu C; Roman A; Rotaru R; Fica S
Rev Med Chir Soc Med Nat Iasi; 2006; 110(2):291-4. PubMed ID: 17802933
[TBL] [Abstract][Full Text] [Related]
19. Association between low lean body mass and osteoporotic fractures after menopause.
Capozza RF; Cure-Cure C; Cointry GR; Meta M; Cure P; Rittweger J; Ferretti JL
Menopause; 2008; 15(5):905-13. PubMed ID: 18520697
[TBL] [Abstract][Full Text] [Related]
20. [Genetic polymorphism of vitamin D receptor and osteoporosis].
Sosa Henríquez M; Torres Ramírez A; Domínguez Cabrera C; Salido E; Saavedra Santana P; Barrios Y; Limiñana Cañal JM; Betancor León P
Med Clin (Barc); 1998 May; 110(17):646-50. PubMed ID: 9656208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
